These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20302758)

  • 1. [Protective role of MMP-9 inhibitor batimastat in acute lung injury after cardiopulmonary bypass].
    Ge SL; Gong WH; Zhang CX; Zhang L; Han PH; Zhang SQ; Feng JB; Zhou DC
    Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(1):57-61. PubMed ID: 20302758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
    Asahi M; Asahi K; Jung JC; del Zoppo GJ; Fini ME; Lo EH
    J Cereb Blood Flow Metab; 2000 Dec; 20(12):1681-9. PubMed ID: 11129784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline attenuates acute lung injury following cardiopulmonary bypass: involvement of matrix metalloproteinases.
    Wang CT; Zhang L; Wu HW; Wei L; Xu B; Li DM
    Int J Clin Exp Pathol; 2014; 7(11):7460-8. PubMed ID: 25550781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of batimastat on the dynamic changes of matrix metalloproteinases in liver tissue during the development of hepatocellular carcinoma in rats].
    Gao Y; Zhang Z; Jiang ZS; Fang SG; Sun EW; Liu J; Chen BH
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):570-1. PubMed ID: 14552732
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermolysin activates equine lamellar hoof matrix metalloproteinases.
    Mungall BA; Pollitt CC
    J Comp Pathol; 2002 Jan; 126(1):9-16. PubMed ID: 11814317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: understanding the role of metalloproteinases in envenomation.
    Rucavado A; Escalante T; Gutiérrez JM
    Toxicon; 2004 Mar; 43(4):417-24. PubMed ID: 15051405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of disequilibrium of expression of matrix metalloproteinase-2/9 and their tissue inhibitors in pathogenesis of hyperoxia-induced acute lung injury in mice].
    Zhang XF; Zhu GF; Liu S; Foda HD
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Oct; 20(10):597-600. PubMed ID: 18926070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
    Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
    J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice.
    Corbel M; Lanchou J; Germain N; Malledant Y; Boichot E; Lagente V
    Eur J Pharmacol; 2001 Aug; 426(1-2):113-21. PubMed ID: 11525779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloproteinase inhibition by batimastat does not reduce neointimal thickening in stented atherosclerotic porcine femoral arteries.
    van Beusekom HM; Post MJ; Whelan DM; de Smet BJ; Duncker DJ; van der Giessen WJ
    Cardiovasc Radiat Med; 2003; 4(4):186-91. PubMed ID: 15321056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model.
    Scott KA; Holdsworth H; Balkwill FR; Dias S
    Br J Cancer; 2000 Dec; 83(11):1538-43. PubMed ID: 11076665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C attenuates cardiopulmonary bypass-induced acute lung injury through the regulation of neutrophil activation.
    Yamazaki S; Inamori S; Nakatani T; Suga M
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1246-52. PubMed ID: 20605027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alterations of metalloproteinases and their inhibitors concentrations in peripheral blood in children with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass].
    Paśnik J; Cywińska-Bernas A; Moll J; Moll J; Sysa A; Zeman K
    Przegl Lek; 2009; 66(7):359-64. PubMed ID: 20043576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
    Low JA; Johnson MD; Bone EA; Dickson RB
    Clin Cancer Res; 1996 Jul; 2(7):1207-14. PubMed ID: 9816289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.
    Watson SA; Morris TM; Robinson G; Crimmin MJ; Brown PD; Hardcastle JD
    Cancer Res; 1995 Aug; 55(16):3629-33. PubMed ID: 7627972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger.
    Mayers I; Hurst T; Radomski A; Johnson D; Fricker S; Bridger G; Cameron B; Darkes M; Radomski MW
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):661-8. PubMed ID: 12658210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
    Giavazzi R; Garofalo A; Ferri C; Lucchini V; Bone EA; Chiari S; Brown PD; Nicoletti MI; Taraboletti G
    Clin Cancer Res; 1998 Apr; 4(4):985-92. PubMed ID: 9563894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
    Eccles SA; Box GM; Court WJ; Bone EA; Thomas W; Brown PD
    Cancer Res; 1996 Jun; 56(12):2815-22. PubMed ID: 8665519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation.
    Bourlier V; Zakaroff-Girard A; De Barros S; Pizzacalla C; de Saint Front VD; Lafontan M; Bouloumié A; Galitzky J
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1272-9. PubMed ID: 15537822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.